ATLASPharmaCyte Biotech (PMCB) earnings date: Dec 17, 2026
PharmaCyte Biotech (PMCB) reports earnings for the quarter ended Oct 31, 2026 on Thu, Dec 17, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PMCB
| Last price | $0.31 (+2.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 6 reports |
These figures come from the same calibrated model and valuation as the PharmaCyte Biotech stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
PharmaCyte Biotech reports on Dec 17, 2026. One email the day before, with ATLAS’s read on PharmaCyte Biotech. You can switch it off at any time.
Alert me before PMCB reportsFree to start. Creating an account takes under a minute.
Notify me when PharmaCyte Biotech reports
Track PMCB free Add PharmaCyte Biotech to a free ATLAS watchlist and see its next report date in one place.
PMCB earnings at a glance
| Next report (confirmed) | Thu, Dec 17, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Oct 31, 2026 |
| Last report | Sep 14, 2026 · Miss |
| Beat rate (last 6 reports) | 2 of 6 (33%) |
| Average EPS surprise | +6.3% |
| Average move around a report | ±4.7% (last 6) |
| Sector | Healthcare · Biotechnology |
PharmaCyte Biotech earnings history: last 6 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 14, 2026 | – | -$0.54 | – | Miss | -15.1% |
| Jul 29, 2026 | – | -$0.01 | – | Miss | +1.7% |
| Mar 17, 2026 | $0.00 | -$0.17 | – | Miss | -0.1% |
| Feb 12, 2026 | $1.03 | $1.07 | +3.9% | Beat | -6.1% |
| Nov 7, 2025 | $0.60 | $0.69 | +15.0% | Beat | +4.5% |
| Apr 28, 2024 | -$0.07 | -$0.07 | 0.0% | In line | +0.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PMCB
See the fair value, the probability range and the earnings history of PharmaCyte Biotech on its ATLAS page.
PharmaCyte Biotech (PMCB) stock analysisPlans from €3.99 a month.
PharmaCyte Biotech earnings: frequently asked questions
When does PharmaCyte Biotech (PMCB) report earnings?
PharmaCyte Biotech is scheduled to report on Thursday, December 17, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does PMCB beat earnings estimates?
Of its last 6 reports with a recorded result, PharmaCyte Biotech beat the EPS estimate 2 times; the average surprise was +6.3%. Past results do not predict the next one.
How much does PMCB move around earnings?
Over its last 6 reports the stock moved an average of 4.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
How much does PMCB usually move in a day?
On a normal trading day the ATLAS model puts PMCB’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Dec 17, 2026
Educational information, not investment advice. Disclaimer